Standard Glass Lining Technology Ltd is specialized engineering equipment manufacturer for pharmaceutical and chemical sectors in India. It portfolio comprises core equipment's used in the manufacturing of pharmaceutical and chemical products, which can be categorized into: (i) Reaction Systems; (ii) Storage, Separation and Drying Systems; and (iii) Plant, Engineering and Services (including other ancillary parts). The Group is engaged in the manufacturing of pharmaceutical glass lined equipment, metal equipment & pumps and polytetrafluoroethylene (PTFE) line equipment. Key revenue is generated from metal equipment & pumps.
2012
460
LTM Revenue $78.6M
LTM EBITDA $14.5M
$407M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Standard Glass Lining has a last 12-month revenue (LTM) of $78.6M and a last 12-month EBITDA of $14.5M.
In the most recent fiscal year, Standard Glass Lining achieved revenue of $71.9M and an EBITDA of $14.0M.
Standard Glass Lining expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Standard Glass Lining valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $78.6M | XXX | $71.9M | XXX | XXX | XXX |
Gross Profit | $78.6M | XXX | $31.5M | XXX | XXX | XXX |
Gross Margin | 100% | XXX | 44% | XXX | XXX | XXX |
EBITDA | $14.5M | XXX | $14.0M | XXX | XXX | XXX |
EBITDA Margin | 18% | XXX | 20% | XXX | XXX | XXX |
EBIT | $13.1M | XXX | $11.3M | XXX | XXX | XXX |
EBIT Margin | 17% | XXX | 16% | XXX | XXX | XXX |
Net Profit | $9.6M | XXX | $7.5M | XXX | XXX | XXX |
Net Margin | 12% | XXX | 10% | XXX | XXX | XXX |
Net Debt | XXX | XXX | $4.4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Standard Glass Lining's stock price is INR 184 (or $2).
Standard Glass Lining has current market cap of INR 36.7B (or $430M), and EV of INR 34.7B (or $407M).
See Standard Glass Lining trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$407M | $430M | XXX | XXX | XXX | XXX | $0.05 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Standard Glass Lining has market cap of $430M and EV of $407M.
Standard Glass Lining's trades at 5.8x EV/Revenue multiple, and 30.2x EV/EBITDA.
Equity research analysts estimate Standard Glass Lining's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Standard Glass Lining has a P/E ratio of 45.0x.
See valuation multiples for Standard Glass Lining and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $430M | XXX | $430M | XXX | XXX | XXX |
EV (current) | $407M | XXX | $407M | XXX | XXX | XXX |
EV/Revenue | 5.2x | XXX | 5.8x | XXX | XXX | XXX |
EV/EBITDA | 28.0x | XXX | 30.2x | XXX | XXX | XXX |
EV/EBIT | 31.1x | XXX | 36.9x | XXX | XXX | XXX |
EV/Gross Profit | 5.2x | XXX | n/a | XXX | XXX | XXX |
P/E | 45.0x | XXX | 58.4x | XXX | XXX | XXX |
EV/FCF | 35.3x | XXX | -83.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialStandard Glass Lining's last 12 month revenue growth is 21%
Standard Glass Lining's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $44K for the same period.
Standard Glass Lining's rule of 40 is 40% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Standard Glass Lining's rule of X is 70% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Standard Glass Lining and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 21% | XXX | 23% | XXX | XXX | XXX |
EBITDA Margin | 18% | XXX | 19% | XXX | XXX | XXX |
EBITDA Growth | 19% | XXX | 21% | XXX | XXX | XXX |
Rule of 40 | 40% | XXX | 40% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 70% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $44K | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 28% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Standard Glass Lining acquired XXX companies to date.
Last acquisition by Standard Glass Lining was XXXXXXXX, XXXXX XXXXX XXXXXX . Standard Glass Lining acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Standard Glass Lining founded? | Standard Glass Lining was founded in 2012. |
Where is Standard Glass Lining headquartered? | Standard Glass Lining is headquartered in India. |
How many employees does Standard Glass Lining have? | As of today, Standard Glass Lining has 460 employees. |
Is Standard Glass Lining publicy listed? | Yes, Standard Glass Lining is a public company listed on NSE. |
What is the stock symbol of Standard Glass Lining? | Standard Glass Lining trades under SGLTL ticker. |
When did Standard Glass Lining go public? | Standard Glass Lining went public in 2025. |
Who are competitors of Standard Glass Lining? | Similar companies to Standard Glass Lining include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
What is the current market cap of Standard Glass Lining? | Standard Glass Lining's current market cap is $430M |
What is the current revenue of Standard Glass Lining? | Standard Glass Lining's last 12 months revenue is $78.6M. |
What is the current revenue growth of Standard Glass Lining? | Standard Glass Lining revenue growth (NTM/LTM) is 21%. |
What is the current EV/Revenue multiple of Standard Glass Lining? | Current revenue multiple of Standard Glass Lining is 5.2x. |
Is Standard Glass Lining profitable? | Yes, Standard Glass Lining is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Standard Glass Lining? | Standard Glass Lining's last 12 months EBITDA is $14.5M. |
What is Standard Glass Lining's EBITDA margin? | Standard Glass Lining's last 12 months EBITDA margin is 18%. |
What is the current EV/EBITDA multiple of Standard Glass Lining? | Current EBITDA multiple of Standard Glass Lining is 28.0x. |
What is the current FCF of Standard Glass Lining? | Standard Glass Lining's last 12 months FCF is $11.5M. |
What is Standard Glass Lining's FCF margin? | Standard Glass Lining's last 12 months FCF margin is 15%. |
What is the current EV/FCF multiple of Standard Glass Lining? | Current FCF multiple of Standard Glass Lining is 35.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.